You are here: Industry Insights > vaccine

News List

Emergex signs agreement with George Mason University for highly pathogenic RNA virus studies pharmaceutical-business-review
April 24, 2020
Emergex Vaccines Holding, a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, announced that it has entered into an agreement with the George Mason University, based in Virginia, in the United States.
Griffith University and IIL team up to develop Covid-19 vaccine pharmaceutical-technology
April 24, 2020
Griffith University in Australia has partnered with vaccines manufacturing company Indian Immunologicals (IIL) to develop a Covid-19 vaccine.
J&J strikes deal with Emergent BioSolutions on coronavirus vaccine manufacturing expresspharma
April 24, 2020
Under the deal, valued at about $135 million, Emergent said it would provide drug substance manufacturing services and was reserving large-scale manufacturing capacity.
MIT researchers in US advance Covid-19 vaccine into preclinical tests pharmaceutical-technology
April 23, 2020
A research team at the Massachusetts Institute of Technology (MIT) in the US have advanced a Covid-19 vaccine candidate into preclinical tests in animal models.
Germany approves trials of COVID-19 vaccine candidate expresspharma
April 23, 2020
The trial, only the fourth worldwide of a vaccine targeting the virus, will be initially conducted on 200 healthy people, with more subjects, including some at higher risk from the disease, to be included in a second stage, German vaccines regulator the P
UK COVID-19 vaccine to begin human testing pharmatimes
April 22, 2020
As of this morning – Wednesday April 22 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 129,044 with 17,337 deaths.
BARDA to give Moderna up to $483 million for COVID-19 vaccine development europeanpharmaceuticalreview
April 22, 2020
The US Biomedical Advanced Research and Development Authority (BARDA) will fund Moderna’s COVID-19 vaccine candidate mRNA-1273 through Phase II and III clinical trials to FDA licensure.
University of Georgia’s Covid-19 vaccine shows promise in test models pharmaceutical-technology
April 22, 2020
A Covid-19 vaccine candidate developed by a research team at the University of Georgia (UGA) College of Veterinary Medicine has shown promise in test models.
US NIH to launch international alliance for Covid-19 drugs and vaccine pharmaceutical-technology
April 21, 2020
The US National Institutes of Health (NIH) is set to launch a public-private partnership, which will bring together health agencies and pharmaceutical companies to accelerate Covid-19 drugs and vaccines.
ABL Supports Fill/Finish of COVID-19 Vaccine Candidate contractpharma
April 20, 2020
Utilizes its aseptic fill/finish facility to support confidential clients' COVID-19 vaccine development.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page